Estrogen, medroxyprogesterone acetate, endothelial function, and biomarkers of cardiovascular risk in young women.
about
Kaempferol Exhibits Progestogenic Effects in Ovariectomized RatsA combined oral contraceptive containing 30 mcg ethinyl estradiol and 3.0 mg drospirenone does not impair endothelium-dependent vasodilation.Endothelial function, endothelin-1, and fibrinogen in young women using the vaginal contraceptive ring.Depot-medroxyprogesterone acetate and endothelial function before and after acute oral, vaginal, and transdermal estradiol treatmentShort-term oral progesterone administration antagonizes the effect of transdermal estradiol on endothelium-dependent vasodilation in young healthy women.Peripheral Microvascular Vasodilatory Response to Estradiol and Genistein in Women with Insulin ResistanceOral contraceptive use, iron stores and vascular endothelial function in healthy womenEstrogen Therapy and Ischemic Stroke in Women with Diabetes Aged Over 55 Years: A Nation-Wide Prospective Population-Based Study in Taiwan.ETB receptor contribution to vascular dysfunction in postmenopausal women.Oral contraceptive progestins and angiotensin-dependent control of the renal circulation in humansChallenges and methodology for testing young healthy women in physiological studies.Blood pressure and water regulation: understanding sex hormone effects within and between men and women.Effects of regular aerobic exercise on post-exercise vagal reactivation in young female.Effects of the contraceptive skin patch and subdermal contraceptive implant on markers of endothelial cell activation and inflammation.Evaluation of the coagulation profile among oral and vaginal combined hormonal contraceptive users using sonoclot coagulation analyzer.The relationship between shear rate and flow-mediated dilation is altered by acute exercise.
P2860
Q28260010-9D36E30C-CB22-4264-8274-F7FB17011BE1Q34145361-46C24D51-EE4E-4AC4-AD3D-911EFD0D7FFBQ34447839-87ECDE0E-A235-4051-B57C-3141DC7C7491Q34727876-836E661E-1B4A-42B5-B233-0E76437529B1Q35396665-756006E3-4D1D-462C-9383-43D042B083B2Q35638068-FB8DDE59-A26F-48CD-BF71-7BCE41B596CBQ35774926-4077D369-BB12-4ADC-A775-500F202FE3F9Q35866986-C789E8ED-FCD7-4694-8B1E-5FAD3DD79A84Q36355674-B4AF9656-DB07-4B11-82BD-58FB17139737Q37016804-E091C6DA-157B-4412-9AA6-9D40C2C9513FQ37707646-AA089181-AB0B-48E8-8B8B-F4DC8DD95334Q38048735-B3031388-A913-4E77-8D4E-3266D0BA2E21Q45038466-AE836891-41CE-47A6-835B-DB38F1CA6FA0Q50961888-E5F55B94-59FB-4E50-AAD5-F060B4EEBCCCQ51365511-1167901E-1164-47D2-BEA7-E6AB54B02542Q53677372-69AF12EC-6512-43CB-B7C1-FF477D91E0F9
P2860
Estrogen, medroxyprogesterone acetate, endothelial function, and biomarkers of cardiovascular risk in young women.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Estrogen, medroxyprogesterone ...... ovascular risk in young women.
@ast
Estrogen, medroxyprogesterone ...... ovascular risk in young women.
@en
Estrogen, medroxyprogesterone ...... ovascular risk in young women.
@nl
type
label
Estrogen, medroxyprogesterone ...... ovascular risk in young women.
@ast
Estrogen, medroxyprogesterone ...... ovascular risk in young women.
@en
Estrogen, medroxyprogesterone ...... ovascular risk in young women.
@nl
prefLabel
Estrogen, medroxyprogesterone ...... ovascular risk in young women.
@ast
Estrogen, medroxyprogesterone ...... ovascular risk in young women.
@en
Estrogen, medroxyprogesterone ...... ovascular risk in young women.
@nl
P2093
P2860
P921
P1476
Estrogen, medroxyprogesterone ...... ovascular risk in young women.
@en
P2093
Britta N Torgrimson
Christopher T Minson
Jessica R Meendering
Nicole P Miller
Paul F Kaplan
P2860
P304
P356
10.1152/AJPHEART.01314.2007
P577
2008-02-15T00:00:00Z